Alan W. Partin

Alan W. Partin

Johns Hopkins University

H-index: 133

North America-United States

About Alan W. Partin

Alan W. Partin, With an exceptional h-index of 133 and a recent h-index of 59 (since 2020), a distinguished researcher at Johns Hopkins University, specializes in the field of Urology Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer

ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins

IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study

PD15-02 LONG-TERM HEALTH RELATED QUALITY OF LIFE IN PROSTATE CANCER PATIENTS REQUIRING RADIOTHERAPY AFTER RADICAL PROSTATECTOMY

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection

Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical Prostatectomy

Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous …

Alan W. Partin Information

University

Position

___

Citations(all)

83546

Citations(since 2020)

16106

Cited By

73454

hIndex(all)

133

hIndex(since 2020)

59

i10Index(all)

544

i10Index(since 2020)

255

Email

University Profile Page

Johns Hopkins University

Google Scholar

View Google Scholar Profile

Alan W. Partin Skills & Research Interests

Urology Oncology

Top articles of Alan W. Partin

Title

Journal

Author(s)

Publication Date

Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer

JAMA oncology

Jeffrey J Tosoian

Yuping Zhang

Lanbo Xiao

Cassie Xie

Nathan L Samora

...

2024/4/18

ERG Status at the Margin Is Associated With Biochemical Recurrence After Radical Prostatectomy With Positive Surgical Margins

Modern Pathology

Daniela C Salles

Adrianna A Mendes

Misop Han

Alan W Partin

Bruce J Trock

...

2023/7/1

IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study

Urology

Jason M Scovell

Mark Stovsky

Alan Partin

Yair Lotan

Jack Baniel

...

2023/5/1

PD15-02 LONG-TERM HEALTH RELATED QUALITY OF LIFE IN PROSTATE CANCER PATIENTS REQUIRING RADIOTHERAPY AFTER RADICAL PROSTATECTOMY

The Journal of Urology

T Anders Olsen

Sagar Patel

Dattatraya Patil

Louis Alperti

Joseph Smith

...

2023/4

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection

Cancers (Basel)

Zhang H Höti N

Lih TS

Dong M

Zhang Z

Mangold L

...

2023/2

Machine Learning for the Prediction of Adverse Pathological Outcomes in Patients Treated with Radical Prostatectomy

International journal of radiation oncology, biology, physics

A Sabbagh

D Tilki

AW Partin

B Trock

MH Chen

...

2023/10/1

Development and external validation of a machine learning model for prediction of lymph node metastasis in patients with prostate cancer

European Urology Oncology

Ali Sabbagh

Samuel L Washington 3rd

Derya Tilki

Julian C Hong

Jean Feng

...

2023/10/1

Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous …

Medical Oncology

Diane K Reyes

Bruce J Trock

Phuoc T Tran

Christian P Pavlovich

Curtiland Deville

...

2022/4/28

Urinary marker panels for aggressive prostate cancer detection

Scientific reports

Tung-Shing Mamie Lih

Mingming Dong

Leslie Mangold

Alan Partin

Hui Zhang

2022/9/1

ISOPSA: Clinical Performance of a Single Parameter, Structure Based Test for High Grade Prostate Cancer Unaffected by 5-ARI and A-Blocker Medications

Eric Klein

Alan Partin

Yair Lotan

Jack Baniel

Martin Dineen

...

2022

Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter study

Urologic Oncology: Seminars and Original Investigations

Eric A Klein

Alan Partin

Yair Lotan

Jack Baniel

Martin Dineen

...

2022/9/1

Prospective multicenter comparison of open and robotic radical prostatectomy: the PROST-QA/RP2 consortium

The Journal of urology

Peter Chang

Andrew A Wagner

Meredith M Regan

Joseph A Smith

Christopher S Saigal

...

2022/1

Cell Cycle Progression Score, But Not PTEN Loss, Is an Independent Prognostic Factor for Metastasis in Intermediate-and High-Risk Prostate Cancer in Men Treated with and …

The Journal of Urology

BJ Trock

Y Jing

B Mabey

Z Sangale

L Lenz

...

2022/8/25

1.5: RENAL SYSTEM

Pediatric Anesthesia: A Comprehensive Approach to Safe and Effective Care

AW Partin

RR Dmochowski

LR Kavoussi

C Peters

2022/8/5

Cell cycle progression score, but not phosphatase and tensin homolog loss, is an independent prognostic factor for metastasis in intermediate-and high-risk prostate cancer in …

The Journal of urology

Bruce J Trock

Yuezhou Jing

Brent Mabey

Zaina Sangale

Lauren Lenz

...

2022/12

Predicting high-grade prostate cancer at initial biopsy: clinical performance of the ExoDx (EPI) Prostate Intelliscore test in three independent prospective studies

Prostate cancer and prostatic diseases

Erik Margolis

Gordon Brown

Alan Partin

Ballentine Carter

James McKiernan

...

2022/6

Machine Learning for the Prediction of Lymph Node Metastasis in Patients with Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics

A Sabbagh

S Washington III

D Tilki

JC Hong

J Feng

...

2022/11/1

Feasibility of integrating canine olfaction with chemical and microbial profiling of urine to detect lethal prostate cancer

PLoS One

Claire Guest

Rob Harris

Karen S Sfanos

Eva Shrestha

Alan W Partin

...

2021/2/17

Effect of erythropoietin on erectile function after radical prostatectomy: the ERECT randomized clinical trial

The Journal of urology

Hiten D Patel

Zeyad R Schwen

Jeffrey D Campbell

Michael A Gorin

Alan W Partin

...

2021/6

MP60-03 ISOPSA: CLINICAL PERFORMANCE OF A SINGLE PARAMETER, STRUCTURE BASED TEST FOR HIGH GRADE PROSTATE CANCER IN A LARGE, MULTICENTER, PROSPECTIVE VALIDATION TRIAL

Journal of Urology

Eric Klein

Alan Partin

Yair Lotan

Jack Baniel

Martin Dineen

...

2021/9/1

See List of Professors in Alan W. Partin University(Johns Hopkins University)

Co-Authors

H-index: 175
Jonathan Epstein

Jonathan Epstein

Johns Hopkins University

H-index: 145
Kenneth Pienta

Kenneth Pienta

Johns Hopkins University

H-index: 136
William B. Isaacs

William B. Isaacs

Johns Hopkins University

H-index: 128
Angelo M. De Marzo M.D., Ph.D.

Angelo M. De Marzo M.D., Ph.D.

Johns Hopkins University

H-index: 107
William G. Nelson

William G. Nelson

Johns Hopkins University

H-index: 101
Mario Eisenberger

Mario Eisenberger

Johns Hopkins University

academic-engine